The surge of Human Metapneumovirus (HMPV) cases in India, coupled with the absence of any approved vaccine, has spotlighted diagnostic companies as increased testing needs drive demand for molecular diagnostics and respiratory panels. This emerging health concern creates significant opportunities in the diagnostic sector, particularly for firms with established testing infrastructure and virus detection capabilities.
Below is a list of stocks expected to perform well in the event of health crises:
1. Thyrocare Technologies
A leading Indian diagnostic lab offering over 700 affordable tests via 800+ centres. Founded in 2000, it emphasises preventive healthcare, timely results, and quality with multiple international accreditations.
Thyrocare Technologies share price rose 15.35% to Rs. 1,055 on Monday, up from Rs. 914.55. Its market capitalisation reached around Rs. 5,542 crore as of January 6, 2025.
2. Vijay Diagnostic
A major diagnostic player in India, offering pathology and radiology services through 80+ centres. Known for accuracy and efficient delivery, it prioritises customer satisfaction and employs advanced technology for reliable testing.
Vijay Diagnostic share price rose 4.33% to Rs. 1,160.15 on Monday, up from Rs. 1,112. Its market capitalisation reached around Rs. 11,491 crore as of January 6, 2025.
3. Metropolis Healthcare
Operating 125 labs and 2,000+ centres, Metropolis provides comprehensive diagnostics. Established in 1980, it’s recognised for quality, innovation, and advanced technology, ensuring accurate results and timely services across multiple medical domains.
Metropolis Healthcare share price rose 2.96% to Rs. 2,057 on Monday, up from Rs. 1,997.80. Its market capitalisation reached around Rs. 10,405 crore as of January 6, 2025.
4. Dr. Lal PathLabs
India’s largest diagnostic chain with 200+ labs and numerous centres. Founded in 1949, it offers diverse tests with a focus on accuracy, reliability, and digital expansion to enhance patient experience.
Dr. Lal PathLabs share price rose 4.49% to Rs. 3,077.05 on Monday, up from Rs. 2,944.65. Its market capitalisation reached around Rs. 24,902 crore as of January 6, 2025.
Also read….
5. Abbott India
A subsidiary of Abbott Laboratories, offering pharmaceuticals and devices across nutrition, cardiovascular, and diagnostics. Focused on innovation, it delivers advanced, localised healthcare solutions for improved patient outcomes.
Abbott India share price rose 1.59% to Rs. 29,960 on Monday, up from Rs. 29,490.20. Its market capitalisation reached around Rs. 40,886 crore as of January 6, 2025.
6. Ajanta Pharma
Leading Indian pharmaceutical company since 1973, providing affordable, high-quality generics in 30+ countries. Known for research-driven innovation, it manufactures medications across therapeutic areas, enhancing global patient accessibility.
Ajanta Pharma share price rose 3.66% to Rs. 2,978.95 on Monday, up from Rs. 2,873.75. Its market capitalisation reached around Rs. 37,061 crore as of January 6, 2025.
7. Granules India
Granules India, established in 1991, is a leading pharmaceutical company based in Hyderabad, specialising in APIs, PFIs, and finished dosages. It operates globally, with 8 facilities, a strong R&D focus, and a vertically integrated business model.
Granules India share price rose 2.35% to Rs. 619.45 on Monday, up from Rs. 605.20. Its market capitalisation reached around Rs. 14,896 crore as of January 6, 2025.
Written by Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
